Professionals in the healthcare industry are looking to tailor medicine to specific patients after thorough genetic medical diagnosis. Regulatory affairs managers are petitioning that not only is this more cost effective for the industry, but also will result in better treatment for patients. The use of genetics in combination with effective medical diagnosis is not an everyday practice, but if incorporated into daily healthcare activity will benefit the industry greatly.
Currently medical practices do not make full use of genomic practices with diagnosis. Often doctors will treat patients with medicine A to treat the condition. If medicine A causes a negative reaction or has no effect, then Medicine B is given out. The consequences of this methodology are that patients are often unwilling to seek treatment and costs are much higher to get the desired results. Incorporating genomic medical diagnosis means that by analysing the DNA thread of patients, doctors can know beforehand the genetic factors that impact the treatment, making it cost effective as the right medicine can be prescribed immediately.
The costs of genetic testing will be very low across the board, making it a viable option to be incorporated in medical diagnosis. This development will ease the complexity of a pharmacovigilance job, as it well reduce trial and error of prescription treatment and ensure that patients get the right medicine for their system. Efforts are being brought to have this system in place within the next 2 years to improve healthcare and drive down the high medical diagnosis cost across the industry.